Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion

Journal of Infection and Chemotherapy

Volumn 23, Issue 7, 2017, Pages 485-487

  Akahoshi, Yu ^a   Kanda, Junya ^a   Ohno, Ayumu ^b   Komiya, Yusuke ^a   Gomyo, Ayumi ^a   Hayakawa, Jin ^a   Harada, Naonori ^a   Kameda, Kazuaki ^a   Ugai, Tomotaka ^a   Wada, Hidenori ^a   Ishihara, Yuko ^a   Kawamura, Koji ^a   Sakamoto, Kana ^a   Sato, Miki ^a   Terasako Saito, Kiriko ^a   Kimura, Shun ichi ^a   Kikuchi, Misato ^a   Nakasone, Hideki ^a   Kako, Shinichi ^a   Shiraki, Kimiyasu ^b   Kanda, Yoshinobu ^a   more..

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Herpes simplex virus; In vivo T cell depletion; Virological resistance

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; CD33 ANTIGEN; CD34 ANTIGEN; CEFEPIME; CYCLOPHOSPHAMIDE; FOSCARNET; HLA DR ANTIGEN; HYDROCORTISONE; MEROPENEM; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VANCOMYCIN; VIRUS ANTIGEN; ANTIVIRUS AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE MYELOID LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CASE REPORT; CBFBETA GENE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CONSOLIDATION CHEMOTHERAPY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHILIA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; GENE; GENE FUSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOPHENOTYPING; IMMUNOPROPHYLAXIS; INDUCTION CHEMOTHERAPY; LEUKEMIA REMISSION; LOW DRUG DOSE; MOUTH ULCER; MUCOSA INFLAMMATION; MYELOABLATIVE CONDITIONING; MYH11 GENE; ORAL MUCOSITIS; PALATE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID THERAPY; T CELL DEPLETION; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; DRUG EFFECTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN ALPHAHERPESVIRUS 1; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; PATHOLOGY; T LYMPHOCYTE; TONGUE; VIROLOGY;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; T-LYMPHOCYTES; TONGUE; TRANSPLANTATION, HOMOLOGOUS;

EID: 85014129854     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2017.02.001     Document Type: Article

References (14)

1. Saral, R., Burns, W.H., Laskin, O.L., Santos, G.W., Lietman, P.S., Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med 305 (1981), 63–67.
2. Wade, J.C., Newton, B., Flournoy, N., Meyers, J.D., Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 100 (1984), 823–828.
3. Kawamura, K., Wada, H., Yamasaki, R., Ishihara, Y., Sakamoto, K., Ashizawa, M., et al. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 15 (2013), 457–465.
4. Chakrabarti, S., Pillay, D., Ratcliffe, D., Cane, P.A., Collingham, K.E., Milligan, D.W., Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis 181 (2000), 2055–2058.
5. Kim, J.H., Schaenman, J.M., Ho, D.Y., Brown, J.M., Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Biol Blood Marrow Transpl 17 (2011), 259–264.
6. Chen, Y., Scieux, C., Garrait, V., Socie, G., Rocha, V., Molina, J.M., et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 31 (2000), 927–935.
7. Darville, J.M., Ley, B.E., Roome, A.P., Foot, A.B., Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population. Bone Marrow Transpl 22 (1998), 587–589.
8. Langston, A.A., Redei, I., Caliendo, A.M., Somani, J., Hutcherson, D., Lonial, S., et al. Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood 99 (2002), 1085–1088.
9. Piret, J., Boivin, G., Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 55 (2011), 459–472.
10. Safrin, S., Kemmerly, S., Plotkin, B., Smith, T., Weissbach, N., De Veranez, D., et al. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis 169 (1994), 193–196.
11. Daikoku, T., Tannai, H., Honda, M., Onoe, T., Matsuo, K., Onoye, Y., et al. Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy. J Dermatol Sci 82 (2016), 160–165.
12. Ida, M., Kageyama, S., Sato, H., Kamiyama, T., Yamamura, J., Kurokawa, M., et al. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants. Antivir Res 40 (1999), 155–166.
13. Sasadeusz, J.J., Tufaro, F., Safrin, S., Schubert, K., Hubinette, M.M., Cheung, P.K., et al. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J Virol 71 (1997), 3872–3878.
14. Reusser, P., Cordonnier, C., Einsele, H., Engelhard, D., Link, D., Locasciulli, A., et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transpl 17 (1996), 813–817.